Found: 10
Select item for more details and to access through your institution.
Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28907-3
- By:
- Publication type:
- Article
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 95, doi. 10.1111/apt.16923
- By:
- Publication type:
- Article
The Italian registry of therapeutic apheresis: Granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
- Published in:
- Journal of Clinical Apheresis, 2011, v. 26, n. 6, p. 332, doi. 10.1002/jca.20315
- By:
- Publication type:
- Article
Association between Ustekinumab Trough Levels, Serum IL-22, and Oncostatin M Levels and Clinical and Biochemical Outcomes in Patients with Crohn's Disease.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 6, p. 1539, doi. 10.3390/jcm13061539
- By:
- Publication type:
- Article
Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test.
- Published in:
- Pathogens, 2021, v. 10, n. 5, p. 535, doi. 10.3390/pathogens10050535
- By:
- Publication type:
- Article
Risk factors for Barrett's esophagus: A case-control study.
- Published in:
- International Journal of Cancer, 2002, v. 97, n. 2, p. 225, doi. 10.1002/ijc.1583
- By:
- Publication type:
- Article
Endoscopic injection sclerotherapy in non-variceal upper gastrointestinal bleeding. A comparative study of polidocanol and thrombin.
- Published in:
- 1991
- By:
- Publication type:
- journal article
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211031420
- By:
- Publication type:
- Article
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211031420
- By:
- Publication type:
- Article
Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2003, v. 98, n. 9, p. 1931, doi. 10.1111/j.1572-0241.2003.07666.x
- By:
- Publication type:
- Article